| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/15/2008 | US7319136 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes/adipocytes/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
| 01/15/2008 | US7319135 PRO1341 polypeptides |
| 01/15/2008 | US7319134 Polypeptide having a modified amino acid sequence of a fragment of nuclear factor-interleukin 6/lymphokine activating protein; activateS various target genes, such as cytokine genes; regulation of gene expression; antiproliferative agents |
| 01/15/2008 | US7319094 Increased and sustained in vivo gene expression using a nucleic acid, histone and amphipathic compound composition |
| 01/15/2008 | US7319092 Methods of suppressing microglial activation |
| 01/15/2008 | US7319091 Derived from human glioma cells exhibiting monocyte chemotactic activity at a concentration of 1 nM, and exhibiting an estimated molecular mass of 8,400 daltons. |
| 01/15/2008 | US7319090 Methods of treating cerebral ischemia |
| 01/15/2008 | US7319089 Maurocalcine, analogues thereof and their therapeutical uses |
| 01/15/2008 | US7319088 Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof |
| 01/15/2008 | US7319087 Antimicrobial polypeptide from Aspergillus niger |
| 01/15/2008 | US7319086 Method of prophylaxis and treatment and agents useful for same |
| 01/15/2008 | US7319034 Modifications of apoptin |
| 01/15/2008 | US7319019 Biodrug has glial cell mitogenic activity; induce central glial proliferation to induce myelination and treat multiple sclerosis |
| 01/15/2008 | US7319015 Methods and compositions for using alveolar macrophage phospholipase A2 |
| 01/15/2008 | US7319006 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 01/15/2008 | US7318936 Minimization of drug oxidation in drug irradiated excipients formulations |
| 01/15/2008 | US7318934 Method for treating wounds to promote healing |
| 01/15/2008 | US7318931 A protein, e.g., insulin or a growth hormone; a polyol, e.g., mannitol or polyethylene glycol; and a metal, e.g., zinc; stabilized against denaturing when in contact with an organic solvent. |
| 01/15/2008 | US7318927 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 01/15/2008 | US7318926 Complex of antigen, antibodies or ligand, receptors; therapy, prevention of human diseases |
| 01/15/2008 | US7318924 Antibodies against cancer |
| 01/15/2008 | US7318922 Anti-PRO5337 antibodies |
| 01/15/2008 | US7318921 Therapeutic compositions that alter the immune response |
| 01/15/2008 | US7318918 Interferon-alpha polypeptides and conjugates |
| 01/15/2008 | US7318917 for drug screening based on the use of fluorescent 4-(4-dimethylaminostyrl)-N-methylpyridinium (ASP+) |
| 01/15/2008 | US7318840 Intervertebral disc treatment devices and methods |
| 01/15/2008 | CA2400567C Tamper-resistant oral opioid agonist formulations |
| 01/15/2008 | CA2376650C Peptide conjugates for the stabilization of membrane proteins and interactions with biological membranes |
| 01/15/2008 | CA2332559C High molecular weight medicine-containing preparation in powder form for administration through mucosa |
| 01/15/2008 | CA2296769C Modified dorsal tissue affecting factor and compositions |
| 01/15/2008 | CA2290768C Methods and compositions to identify swine genetically resistant to f18 e. coli associated diseases |
| 01/15/2008 | CA2250880C Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 01/15/2008 | CA2221496C Production scale method of forming microparticles |
| 01/15/2008 | CA2216741C A novel protein and process for preparing the same |
| 01/15/2008 | CA2205874C Lipid vesicles containing adeno-associated virus rep protein for transgene integration and gene therapy |
| 01/15/2008 | CA2169191C Neural regeneration using human bone morphogenetic proteins |
| 01/15/2008 | CA2145527C Tissue protective and regenerative compositions |
| 01/15/2008 | CA2134750C Truncated tissue factor and fviia or fvii activator for blood coagulation |
| 01/15/2008 | CA2132740C Pharmaceutical composition containing cyclosporin derivative |
| 01/15/2008 | CA2054762C Production of enzymes in seeds and their use |
| 01/10/2008 | WO2008006103A2 Nogo receptor functional motifs, peptide mimetics, and mutated functional motifs related thereto, and methods of using the same |
| 01/10/2008 | WO2008005985A2 Insulin-like growth factor-1 receptor antagonists |
| 01/10/2008 | WO2008005983A2 Pan-her antagonists and methods of use |
| 01/10/2008 | WO2008005531A2 C-met receptor regulation by angiotensin iv (at4) receptor ligands |
| 01/10/2008 | WO2008005527A2 Glucagon-like peptides and uses thereof |
| 01/10/2008 | WO2008005506A2 An ebv inhibitor and methods of making and using the same |
| 01/10/2008 | WO2008005470A2 Polypeptides that bind membrane proteins |
| 01/10/2008 | WO2008005276A2 Growth factor delivery system containing antimicrobial agents |
| 01/10/2008 | WO2008005084A2 Methods to prevent and treat diseases |
| 01/10/2008 | WO2008005021A1 Use of crystallin for the modulation of angiogenesis |
| 01/10/2008 | WO2008004717A1 A stable liquid formulation of human growth hormone |
| 01/10/2008 | WO2008004653A1 Prophylactic or therapeutic agent for viral disease |
| 01/10/2008 | WO2008004610A1 Method of treating genetic disease caused by nonsense mutation |
| 01/10/2008 | WO2008004598A1 Erythropoietin-producing organoid precursor, method of constructing the same and method of treating erythropoietin-related disease |
| 01/10/2008 | WO2008004406A1 Agent for modulating mast cell degranulation |
| 01/10/2008 | WO2008003925A2 Complement protein |
| 01/10/2008 | WO2008003748A2 Cd300lg polypeptides and their use in treating autoimmune diseases |
| 01/10/2008 | WO2008003707A2 Minimized small peptides with high affinity for factor viii and factor viii-like proteins |
| 01/10/2008 | WO2008003688A1 Antimicrobial composition and uses thereof |
| 01/10/2008 | WO2008003612A2 Analogs of vasoactive intestinal peptide |
| 01/10/2008 | WO2008003242A1 Method and ophthalmic formulation for eye protection or treatment |
| 01/10/2008 | WO2007134123A3 Treatment of a wound with a vasodilator |
| 01/10/2008 | WO2007128806A3 Methods for the in vitro screening of compounds inhibiting production of infectious hiv-1 virions |
| 01/10/2008 | WO2007127480A3 Materials and methods to reduce low density lipoprotein cholesterol |
| 01/10/2008 | WO2007121491A8 Hcv vaccinations |
| 01/10/2008 | WO2007115726A3 The homeobox transcription factor bsx and uses thereof for treating diseases, in particular obesity |
| 01/10/2008 | WO2007109620A3 Macrocyclic peptides and methods for making and using them |
| 01/10/2008 | WO2007104738A3 Acylated single chain insulin |
| 01/10/2008 | WO2007104173B1 Method for solubilizing, dispersing, and stabilizing materials, products manufactured according to said method, and use thereof |
| 01/10/2008 | WO2007097951A3 Methods using hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate |
| 01/10/2008 | WO2007079437A3 Combination antitumor therapies |
| 01/10/2008 | WO2007071248A3 Neuritogenic and neuronal survival promoting peptides derived from the family of s-100 proteins |
| 01/10/2008 | WO2007059533A3 Uses for camki i and hdacs in the treatment of heart conditions |
| 01/10/2008 | WO2007053512A3 Novel protein transduction domains and uses therefor |
| 01/10/2008 | WO2007027935A3 Cellular libraries of peptide sequences (clips) and methods of using the same |
| 01/10/2008 | WO2007011434A3 Methods for treating and preventing cancers that express the hypothalamic-pituitary-gonadal axis of hormones and receptors |
| 01/10/2008 | WO2006135621A3 Method for renin-angiotensin-aldosterone system activation and control thereof |
| 01/10/2008 | WO2006089966A8 Fxiii variants with improved properties |
| 01/10/2008 | WO2006068768A3 Methods and compositions for treating conditions |
| 01/10/2008 | WO2005061534A3 Improved tuberculosis vaccines |
| 01/10/2008 | WO2005042002A3 Treatment of rhematoid arthritis with flip antagonists |
| 01/10/2008 | WO2003091400A3 Contraceptive targets |
| 01/10/2008 | US20080010693 Human coagulation factor VII polypeptides |
| 01/10/2008 | US20080009603 Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity |
| 01/10/2008 | US20080009459 Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequences |
| 01/10/2008 | US20080009457 Reaction of Rna and cochleate |
| 01/10/2008 | US20080009448 Peptide Derivative |
| 01/10/2008 | US20080009447 Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of SOCS sequence in the animal |
| 01/10/2008 | US20080009446 Recombinant human albumin fusion proteins with long-lasting biological effects |
| 01/10/2008 | US20080009445 Anti-endotoxic, antimicrobial cationic peptides, the encoding DNA and methods of use thereof |
| 01/10/2008 | US20080009444 Biologically active complex of NR6 and cardiotrophin-like-cytokine |
| 01/10/2008 | US20080009443 Diafiltration system to fractionate protein mixtures |
| 01/10/2008 | US20080009442 Therapeutic use for alpha1 proteinase inhibitor in hematopoiesis |
| 01/10/2008 | US20080009441 Polypeptide Inducing the Secretion of Angiopoietin |
| 01/10/2008 | US20080009440 Soothing Agent and Food for Treating Fatigue |
| 01/10/2008 | US20080009439 Compositions and Methods of Use for a Fibroblast Growth Factor |
| 01/10/2008 | US20080009438 Screening methods for compounds useful in the regulation of body weight |
| 01/10/2008 | US20080009437 Pharmaceutical Compositions and Method for Treating Dry Eye |
| 01/10/2008 | US20080009436 Eye-drops suitable for the treatment of diseases of the eye and surrounding areas; cyclosporin A, castor oil, and Polyoxyethylene 20 (POE (20)) sorbitan monolaurate |
| 01/10/2008 | US20080009435 Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them |